Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors
- 22 November 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 12 (1) , 79-92
Abstract
(2012). Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors. Expert Opinion on Biological Therapy: Vol. 12, No. 1, pp. 79-92. doi: 10.1517/14712598.2012.641011Keywords
This publication has 111 references indexed in Scilit:
- Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemiaThe Lancet, 2011
- Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)American Heart Journal, 2011
- Angiopoietin-2 Confers Atheroprotection in apoE −/− Mice by Inhibiting LDL Oxidation via Nitric OxideCirculation Research, 2009
- Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal MuscleCirculation Research, 2009
- Novel Vascular Endothelial Growth Factor D Variants with Increased Biological ActivityJournal of Biological Chemistry, 2009
- VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN TrialMolecular Therapy, 2009
- VEGF-A and VEGF-F evoke distinct changes in vascular ultrastructureBiochemical and Biophysical Research Communications, 2009
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- Vascular Endothelial Growth Factor (VEGF)-D and VEGF-A Differentially Regulate KDR-mediated Signaling and Biological Function in Vascular Endothelial CellsJournal of Biological Chemistry, 2004
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984